ActivePhase 3Phase 4ACTRN12605000658617

Vitamin D Intervention To Prevent Falls and Fractures and To Promote Mental Well-Being.

Primary Care Prevention of Falls and Fractures in the Elderly by Annual Vitamin D Supplementation.


Sponsor

The University of Melbourne

Enrollment

2,300 participants

Start Date

Feb 24, 2003

Study Type

Interventional

Conditions

Summary

The study hypothesis is that an annual high dose (500,000 IU) of vitamin D2 will reduce the rate of falls and fracture compared with placebo in older women.


Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A Double-Blind Randomised Placebo-Controlled Vitamin D InterventionTrial in which 2,300 women at high risk of fracture are randomised to receive treatment (500,000 IU ergocalciferol orally) or placebo

A Double-Blind Randomised Placebo-Controlled Vitamin D InterventionTrial in which 2,300 women at high risk of fracture are randomised to receive treatment (500,000 IU ergocalciferol orally) or placebo every Autumn/Winter for three to five consecutive years. Participants are asked to complete a diary to record any falls and fractures. This information is collected monthly and confirmed. Participants also complete a validated mental well-being questionnaire at several timepoints throughout the study A subset of 126 women randomly selected undergo more intensive testing throughout the project. At regular intervals these women undergo basic clinical anthropometry, balance and muscle strength assessment; questionnaires to assess mental well-being and pathology testing.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000658617